- Home
- HBIO vs BCV Comparison
HBIO vs BCV Comparison
Compare HBIO & BCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- BCV
- Stock Information
- Founded
- HBIO 1901
- BCV 1971
- Country
- HBIO United States
- BCV United States
- Employees
- HBIO N/A
- BCV N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- BCV Finance/Investors Services
- Sector
- HBIO Industrials
- BCV Finance
- Exchange
- HBIO Nasdaq
- BCV Nasdaq
- Market Cap
- HBIO 93.8M
- BCV 106.0M
- IPO Year
- HBIO 2000
- BCV N/A
- Fundamental
- Price
- HBIO $1.93
- BCV $18.16
- Analyst Decision
- HBIO
- BCV
- Analyst Count
- HBIO 0
- BCV 0
- Target Price
- HBIO N/A
- BCV N/A
- AVG Volume (30 Days)
- HBIO 248.4K
- BCV 26.3K
- Earning Date
- HBIO 03-06-2025
- BCV 01-01-0001
- Dividend Yield
- HBIO N/A
- BCV 8.13%
- EPS Growth
- HBIO N/A
- BCV N/A
- EPS
- HBIO N/A
- BCV N/A
- Revenue
- HBIO $97,732,000.00
- BCV N/A
- Revenue This Year
- HBIO N/A
- BCV N/A
- Revenue Next Year
- HBIO $4.32
- BCV N/A
- P/E Ratio
- HBIO N/A
- BCV N/A
- Revenue Growth
- HBIO N/A
- BCV N/A
- 52 Week Low
- HBIO $1.81
- BCV $14.09
- 52 Week High
- HBIO $4.93
- BCV $18.11
- Technical
- Relative Strength Index (RSI)
- HBIO 40.61
- BCV 54.14
- Support Level
- HBIO $1.81
- BCV $17.78
- Resistance Level
- HBIO $2.07
- BCV $18.03
- Average True Range (ATR)
- HBIO 0.13
- BCV 0.29
- MACD
- HBIO -0.01
- BCV 0.00
- Stochastic Oscillator
- HBIO 25.53
- BCV 63.44
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
About BCV Bancroft Fund Ltd.
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.